Abstract
Chronic kidney disease (CKD) is one of the greatest risk factors for cardiovascular disease (CVD). The contribution of CKD to CVD mortality is not well understood in very elderly patients. Our study examined whether CKD might be a risk factor for total and CVD mortality in very elderly Japanese individuals. A total of 621 participants were enrolled, all of whom were 80 years old. The subjects were divided on the basis of the presence (CKD(+) group, n=280) or absence (CKD(−) group, n=341) of CKD. CKD was defined by as an estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73 m2. The eGFR of the CKD(+) and CKD(−) groups was 49.7±8.5 and 70.9±9.5 mL/min/1.73 m2, respectively. During the 4-year study period, 87 individuals died, and 25 of those deaths were due to CVD. A Cox multivariate regression analysis revealed no association between total mortality and CKD (relative risk [RR] 1.17, confidence interval [CI] 0.75–1.82, p=0.50). However, the CVD mortality was significantly increased in the CKD(+) group (RR 4.60, CI 1.69–12.52, p=0.003). CKD significantly increased the CVD mortality in subjects who were not taking antihypertensive medication (RR 5.15, CI 1.04–25.50, p=0.04). Our results suggest that CKD increases the risk of CVD mortality in very elderly individuals. It is not only important to prevent progression toward CKD in patients who do not suffer from CKD, but also critical to manage the risk factors for CVD in patients with CKD, despite their advanced age.
Similar content being viewed by others
Article PDF
References
Levey AS, Beto JA, Coronado BE, et al: Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853–906.
Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050–1065.
Iseki K : Chronic kidney disease in Japan. Intern Med 2008; 47: 681–689.
Imai E, Horio M, Iseki K, et al: Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007; 11: 156–163.
Public Health Division, Statistics and Information Department, Ministry of Health Labour and Welfare: Online Reporting System of Vital Statistics 2004 ( in Japanese).
Ninomiya T, Kiyohara Y, Kubo M, et al: Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005; 68: 228–236.
Nakamura K, Okamura T, Hayakawa T, et al: Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ J 2006; 70: 954–959.
Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296–1305.
Fried LF, Shlipak MG, Crump C, et al: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41: 1364–1372.
Fried LF, Katz R, Sarnak MJ, et al: Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005; 16: 3728–3735.
Weiner DE, Tabatabai S, Tighiouart H, et al: Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 2006; 48: 392–401.
Kannel WB, Sorlie P, McNamara PM : Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol 1979; 44: 53–59.
Tofler GH, Stone PH, Muller JE, et al: Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987; 9: 473–482.
Maggioni AP, Maseri A, Fresco C, et al: Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med 1993; 329: 1442–1448.
Chen R, Kumar S, Timmis A, Feder G, Yaqoob MM, Hemingway H : Comparison of the relation between renal impairment, angiographic coronary artery disease, and long-term mortality in women versus men. Am J Cardiol 2006; 97: 630–632.
Iseki K, Kinjo K, Iseki C, et al: Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004; 44: 806–814.
Mann JF, Gerstein HC, Pogue J, et al: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629–636.
Hemmelgarn BR, Manns BJ, Zhang J, et al: Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol 2007; 18: 993–999.
Lewis EJ, Hunsicker LG, Clarke WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851–860.
Brenner BM, Cooper ME, de Zeeuw D, et al, RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861–869.
Hunt SA : ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46: e1–e82.
Astor BC, Muntner P, Levin A, et al: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 2002; 162: 1401–1408.
Abramson JL, Jurkovitz CT, Vaccarino V, et al: Chronic kidney disease, anemia, and incident stroke in a middleaged, community-based population: the ARIC Study. Kidney Int 2003; 64: 610–615.
Brown DW, Giles WH, Croft JB : Hematocrit and the risk of coronary heart disease mortality. Am Heart J 2001; 142: 657–663.
Hallan S, Astor B, Romundstad S, et al: Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II Study. Arch Intern Med 2007; 167: 2490–2496.
Beckett NS, Peters R, Fletcher AE, et al: Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887–1898.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kagiyama, S., Matsumura, K., Ansai, T. et al. Chronic Kidney Disease Increases Cardiovascular Mortality in 80-Year-Old Subjects in Japan. Hypertens Res 31, 2053–2058 (2008). https://doi.org/10.1291/hypres.31.2053
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.2053
Keywords
This article is cited by
-
Chronic kidney disease in Polish elderly population aged 75+: results of the WOBASZ Senior Survey
International Urology and Nephrology (2017)
-
Glomerular filtration rate and 10-year mortality in a 70-year-old community-dwelling Japanese population
Aging Clinical and Experimental Research (2011)
-
Prevalence and risk factors for renal artery stenosis and chronic kidney disease in Japanese patients with peripheral arterial disease
Hypertension Research (2010)
-
Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease
Hypertension Research (2009)